- Home
- KZIA vs RDGT Comparison
KZIA vs RDGT Comparison
Compare KZIA & RDGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZIA
- RDGT
- Stock Information
- Founded
- KZIA 1994
- RDGT N/A
- Country
- KZIA Australia
- RDGT China
- Employees
- KZIA N/A
- RDGT N/A
- Industry
- KZIA Biotechnology: Pharmaceutical Preparations
- RDGT
- Sector
- KZIA Health Care
- RDGT
- Exchange
- KZIA Nasdaq
- RDGT NYSE
- Market Cap
- KZIA 5.1M
- RDGT 5.7M
- IPO Year
- KZIA 1999
- RDGT N/A
- Fundamental
- Price
- KZIA $6.10
- RDGT $1.10
- Analyst Decision
- KZIA Strong Buy
- RDGT
- Analyst Count
- KZIA 2
- RDGT 0
- Target Price
- KZIA $57.50
- RDGT N/A
- AVG Volume (30 Days)
- KZIA 2.6M
- RDGT 7.4K
- Earning Date
- KZIA 07-07-2025
- RDGT 07-29-2025
- Dividend Yield
- KZIA N/A
- RDGT N/A
- EPS Growth
- KZIA N/A
- RDGT N/A
- EPS
- KZIA N/A
- RDGT N/A
- Revenue
- KZIA $1,549,158.00
- RDGT $147,126,392.00
- Revenue This Year
- KZIA N/A
- RDGT N/A
- Revenue Next Year
- KZIA N/A
- RDGT N/A
- P/E Ratio
- KZIA N/A
- RDGT N/A
- Revenue Growth
- KZIA 248983.08
- RDGT N/A
- 52 Week Low
- KZIA $2.86
- RDGT $0.72
- 52 Week High
- KZIA $79.00
- RDGT $4.50
- Technical
- Relative Strength Index (RSI)
- KZIA 50.96
- RDGT N/A
- Support Level
- KZIA $5.83
- RDGT N/A
- Resistance Level
- KZIA $9.60
- RDGT N/A
- Average True Range (ATR)
- KZIA 1.19
- RDGT 0.00
- MACD
- KZIA -0.29
- RDGT 0.00
- Stochastic Oscillator
- KZIA 18.39
- RDGT 0.00
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.
About RDGT RIDGETECH INC
Ridgetech Inc formerly China Jo-Jo Drugstores Inc is a retailer and distributor of pharmaceutical products. The company's operating segments include Retail drugstores, Online Pharmacy, and Drug wholesale. Retail drugstores segment sells prescription and over-the-counter medicines, TCM, dietary supplements, medical devices, and sundry items to retail customers. The online pharmacy segment sells drugs through third-party platforms such as Alibaba's Tmall, JD.com, and Amazon.com. It generates maximum revenue from the Retail drugstores segment.